glutathione pathway to triple negative cancer

glutathione pathway to triple negative cancer GSTP1 Is a Driver of Triple-Negative Breast Cell Metabolism and Pathogenicity Recent advances in targeted strategies

Name: glutathione pathway to triple negative cancer GSTP1 Is a Driver of Triple-Negative Breast Cell Metabolism and Pathogenicity Recent advances in targeted strategies
Brand: astonvaughan.co.uk
SKU: 57581285252
Price: 22.07 USD
Availability: InStock
Rating: 4.0135 (6 reviews)

Recent advances in targeted strategies for triple negative breast cancer Journal of Hematology & Oncology Springer Nature Link GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Glutathione is critical for NK cell mediated immunity: Cell Reports

SKU: 57581285252 · From astonvaughan.co.uk

4.0

USD22.07 USD72.07

Pay in 4 interest-free payments of $5.52 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

J.ChangP

Expert Care Our team consists of experienced professionals who are dedicated to your health and well-being

SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis

Early data from Phase 1 and initial Phase 2 investigations helped researchers evaluate the safety profile, pharmacokinetic characteristics, and biological activity of cagrilintide, supporting progression into larger clinical development programs